Name | Value |
---|---|
Revenues | 295.3M |
Cost of Revenue | 80.9M |
Gross Profit | 214.4M |
Operating Expense | 189.8M |
Operating I/L | 4.3M |
Other Income/Expense | -7.2M |
Interest Income | 0.8M |
Pretax | -2.8M |
Income Tax Expense | -0.8M |
Net Income/Loss | -2.0M |
NuVasive, Inc. is a medical technology company specializing in procedural solutions for spine surgery. The company develops and sells surgical access instruments, spinal implants, fixation systems, cervical total disc replacement technology, neuromonitoring systems, and the Pulse platform. Additionally, it offers expandable growing rod implant systems, biologics for spinal fusion, Precice intramedullary implant device, and onsite and remote monitoring of neurological systems for patients undergoing spinal and brain-related surgeries. NuVasive generates revenue by selling its products to patients, surgeons, hospitals, and insurers through independent sales agents, employed sales personnel, and distributors in the United States and internationally.